Skip to main content
. 2009 Sep 3;32(12):2275–2280. doi: 10.2337/dc09-0798

Figure 3.

Figure 3

Means ± SEM plasma glucagon concentrations (left panels) and change in plasma glucagon from zero time (right panels) before and after ingestion of a mixed meal (top panels) and of the sulfonylurea glimepiride (bottom panels) in basal insulin–infused patients with type 1 diabetes (T1DM) (●) and nondiabetic (ND) individuals (○). Differences in baseline-adjusted glucagon levels, P < 0.0001.

HHS Vulnerability Disclosure